Gemtuzumab-induced orchitis in a patient with refractory acute promyelocytic leukaemia
JCPSP-Journal of the College of Physicians and Surgeons Pakistan. 2012; 22 (9): 596-597
in English
| IMEMR
| ID: emr-153040
ABSTRACT
We report the case of a 22-year-old Saudi male patient who was treated extensively in the past with various regimens for acute promyelocytic leukaemia that was refractory to all standard treatments. He was ultimately administered Gemtuzumab to induce remission and subjected to an allogeneic bone marrow transplant. However, he developed orchitis, which has not been previously reported with this agent
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Language:
English
Journal:
J. Coll. Physicians Surg. Pak.
Year:
2012
Similar
MEDLINE
...
LILACS
LIS